Akuvox lanza AKClaw Panel, optimizado para la ejecución nativa de OpenClaw™

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit

Xinhua Silk Road: E China city leverages high-level opening-up to bolster high-quality growth

Global Absorption Chiller Market to Reach USD 2.98 Billion by 2036 as Waste Heat Utilization and District Cooling Drive Sustainable Cooling Adoption

KINGFA Showcases at CHINAPLAS 2026

/C O R R E C T I O N -- NEST/

Hata rondt Series A-financiering van 8 miljoen USD af onder leiding van Bybit

New Report: Half of U.S. Kids Are Breathing Dangerous Air Pollution

U.S. News Announces the 2026 Best Hybrid and Electric Cars

Hata completa un round di finanziamento di Serie A da 8 milioni di dollari guidato da Bybit

How To Protect Yourself During a Sex Crime Investigation | Wichita Criminal Defense Law Firm

Tripadvisor Summer Travel Index Shows East Coast and Florida Beaches as America's Most Sought-After Summer Destinations

ChinaMarket Unveils AI-Driven Sourcing Platform at 5th RCEP Expo, Connecting Global Buyers with Verified Manufacturers

kidSTREAM Children's Museum Announces May 21, 2026 Grand Opening

Hata finaliza una ronda de financiación de Serie A de 8 millones de dólares liderada por Bybit

Hata schließt eine Serie-A-Finanzierungsrunde in Höhe von 8 Millionen US-Dollar unter der Führung von Bybit ab

Persistent meldet für das Geschäftsjahr 2026 einen Umsatz von 1.654,4 Mio. US-Dollar bei einem Wachstum von 17,4 % gegenüber dem Vorjahr und einer EBIT-Marge von 15,6 %

Hata conclut un financement de série A de 8 millions d'USD mené par Bybit

Impac Mortgage Holdings, Inc. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information

Yesway Announces Pricing of Initial Public Offering

Kemper Corporation Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information

Georgia Heritage Financial Credit Union Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information

Ampace Spotlights AI-Ready Battery Solutions for Gigascale Infrastructure at DCW Washington 2026

Dayspring Pharma Announces Phase II Trial of CG2001 Foam Met Primary Endpoint in Chinese Adult Men with AGA

The New Terminal One at JFK Welcomes Saudia as Newest Airline Partner Strengthening Connectivity with Saudi Arabia

Target Hospitality Announces Pricing of Secondary Offering

Family Research Council Responds to SPLC Indictments; Says Accountability Should Include Restitution for those Harmed

Ractigen Therapeutics Presents Positive Phase I Data for RAG-17 in SOD1-ALS at the 2026 AAN Annual Meeting, Demonstrating 81% Reduction in Neurofilament Light Chain

Total Investment of Approx. USD 8.5 Million in Malaria and NTD R&D Projects With Partners Including MMV, GSK, Tanabe Pharma, Eisai and DNDi

Case Report of Mabwell's Nectin-4 targeting ADC (9MW2821) in Cervical Cancer Published in The New England Journal of Medicine